At month 2 of anti-TB therapy, this difference was significant in IL-15 (FC: -4.51, p=0.004), IL-2 (FC: -3.44, p=0.048) and IL-3 (FC: -3.98, p=0.032) (Figure 2B). Here, IL3 is linked to tuberculosis.